Rebound COVID Is Just the Start of Paxlovid’s Mysteries
There’s plenty more to learn about the lifesaving antiviral COVID treatment.
There’s plenty more to learn about the lifesaving antiviral COVID treatment.
Why violence demands not just policy solutions, but public-health ones
Our original-recipe shots are holding up against new variants. But we may need to improve them, and soon.
Genetic testing is a routine part of pregnancy. Abortion restrictions are already shifting how doctors talk about the results.
A new viral outbreak is testing whether the world has learned anything from COVID.
While some parents struggle to get ahold of formula, others with the means and know-how are turning to the black market.
As COVID numbers tick up, hospitals are supposed to be ready to jump in as needed. Only, they never really had a reprieve.
An inspiring research project went viral for the wrong reasons.
America’s current crisis has been in the works for decades.
No one knows exactly why hundreds of kids have shown up with hepatitis, but investigators have some ideas.
Experts are expected to choose a vaccine recipe for the fall, when Omicron may or may not still be the globe’s dominant variant.
Bill Gates has a strategy to save the world from the next infectious threat. He’s not the first.
Early anecdotes about Paxlovid’s effects on long COVID are intriguing, but no one’s testing them in clinical trials yet.
The internet has become strangely nostalgic for life in the Middle Ages.
“I imagine this is what grapefruit juice mixed with soap would taste like.”
Compared with what the U.S. saw in January, the current rise in cases so far looks pretty chill. Is it, though?
With time and effort, we can build enough protection to blunt surges—but herd immunity remains out of reach.
No one’s actually sure.
A new generation of fitness instructors teaches simple skills that make a difference. Why is beginner-level exercise treated like a niche?
Why is this mandate different from all other mandates?